Skip to main content
Synektik S.A. logo

Synektik S.A. — Investor Relations & Filings

Ticker · SNT ISIN · PLSNKTK00019 LEI · 259400U0O19JWLVHQN14 WAR Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country PL Poland
Listing WAR SNT

About Synektik S.A.

https://www.synektik.com.pl/en

Synektik S.A. is a medical technology company providing innovative products, services, and IT solutions for diagnostic imaging, nuclear medicine, and robotic surgery. The company is a leading manufacturer and supplier of radiopharmaceuticals used in oncological diagnostics, particularly for Positron Emission Tomography (PET). In addition to its pharmaceutical operations, Synektik develops specialized medical software, such as Picture Archiving and Communication Systems (PACS), and supplies advanced medical equipment, including the da Vinci robotic surgical systems. It offers comprehensive solutions and support for medical facilities, with a focus on the field of radiology.

Recent filings

Filing Released Lang Actions
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Regulatory Filings Classification · 90% confidence The document is an official announcement by Synektik SA’s management board informing the market of a significant contract award for supply of consumables to a public hospital. It does not contain financial results, voting, share transactions, or request shareholders’ votes, nor is it a presentation or formal report. It is a general regulatory announcement that does not fit any specific category beyond general disclosures. Therefore, it falls under Regulatory Filings (RNS).
2026-05-19 Polish
Wstępne oszacowanie zmian w całkowitym sprawozdaniu z dochodów oraz kapitałach własnych Emitenta w związku z dokonanym wydzieleniem Syn2bio S.A. - Content (PL)
Regulatory Filings Classification · 68% confidence The document is a brief management board notification disclosing preliminary accounting treatment for the spin-off of a business segment and the related effect on equity, stating that final amounts will be included in the interim condensed standalone and consolidated financial statements for the quarter ended March 31, 2026. It does not contain the actual interim financial statements (i.e., comprehensive financial data or full report), nor does it attach or publish a report. It instead serves as a regulatory announcement of an in-progress report preparation and a material corporate action. Therefore it falls under General Regulatory Filings (RNS) rather than a full Interim Report (IR) or Report Publication Announcement (RPA).
2026-05-14 Polish
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (PL)
Regulatory Filings
2026-05-06 Polish
Szacunkowe przychody I półrocza 2025 roku finansowego - Content (PL)
Earnings Release Classification · 85% confidence The document is a short announcement of preliminary financial results for the first half of the fiscal year (key revenue figures only), stating that final consolidated results will be published later. It does not contain full financial statements or detailed interim reporting, but rather highlights initial estimates. This matches an Earnings Release (ER) rather than a full Interim Report or simple publication notice. H1 2026
2026-04-23 Polish
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (PL)
Regulatory Filings Classification · 72% confidence The text is a corporate announcement by Synektik SA’s board informing the market of a significant contract signed by its subsidiary for the sale, installation, and service of a surgical robot system. It is not financial results (no earnings metrics), not a presentation or report, not a dividends notice or share transaction, nor a management change or M&A. It is a standalone regulatory announcement of a material contract, so it defaults to the general “Regulatory Filings” category (RNS).
2026-04-14 Polish
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - Content (PL)
Regulatory Filings Classification · 75% confidence The document is a short (1,233 characters) Polish-language notice providing preliminary segment order intake and backlog figures for a six-month period, with a disclaimer that final results will appear in the upcoming semi-annual report. It is not the full interim or annual report itself, nor an earnings release of profitability metrics, and does not announce a report’s publication link or attachment. This type of trading/operational update falls outside the specific categories and is best treated as a general regulatory announcement (fallback).
2026-04-09 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.